Okey Stephanie Insider Trades

Insider Trading History

Track insider trading activity for Okey Stephanie. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
PTC Therapeutics
PTC Therapeutics PTCT
Director
Holding Value $549k 8,000 shares
Last Trade
Mar 10, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$980k 14,000 shares
$70.00
$68.68
PTC Therapeutics
PTC Therapeutics PTCT
Director
Holding Value $0 0 shares
Last Trade
Mar 10, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$960k 14,000 shares
$68.56
$68.68
PTC Therapeutics
PTC Therapeutics PTCT
Director
Holding Value $1.51M 22,000 shares
Last Trade
Mar 10, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.04M 15,167 shares
$68.56
$68.68
PTC Therapeutics
PTC Therapeutics PTCT
Director
Holding Value $549k 8,000 shares
Last Trade
Mar 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$401k 6,333 shares
$63.38
$68.68
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $440k 13,300 shares
Last Trade
Mar 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$119k 3,000 shares
$39.67
$33.09
PTC Therapeutics
PTC Therapeutics PTCT
Director
Holding Value $824k 12,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$574k 7,475 shares
$76.74
$68.68
PTC Therapeutics
PTC Therapeutics PTCT
Director
Holding Value $549k 8,000 shares
Last Trade
Nov 20, 2025 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$66.3k 867 shares
$76.46
$68.68
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $539k 16,300 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$335k 10,350 shares
$32.33
$33.09
PTC Therapeutics
PTC Therapeutics PTCT
Director
Holding Value $609k 8,867 shares
Last Trade
Mar 13, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$270k 5,000 shares
$54.00
$68.68
PTC Therapeutics
PTC Therapeutics PTCT
Director
Holding Value $952k 13,867 shares
Last Trade
Jan 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$410k 8,800 shares
$46.54
$68.68
Catalent
Catalent CTLT
Director
Holding Value $0 0 shares
Last Trade
Dec 18, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$802k 12,635 shares
$63.48
$63.48
Catalent
Catalent CTLT
Director
Holding Value $802k 12,635 shares
Last Trade
Oct 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$275k 4,663 shares
$58.97
$63.48
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $414k 12,500 shares
Last Trade
Jun 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$559k 12,500 shares
$44.71
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $778k 23,500 shares
Last Trade
Mar 28, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$819k 17,500 shares
$46.81
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $199k 6,000 shares
Last Trade
Mar 28, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$812k 17,500 shares
$46.38
$33.09
PTC Therapeutics
PTC Therapeutics PTCT
Director
Holding Value $687k 10,000 shares
Last Trade
Feb 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$257k 10,000 shares
$25.69
$68.68
Catalent
Catalent CTLT
Director
Holding Value $506k 7,972 shares
Last Trade
Oct 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$275k 6,993 shares
$39.32
$63.48
Catalent
Catalent CTLT
Director
Holding Value $62.1k 979 shares
Last Trade
Aug 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44.7k 979 shares
$45.64
$63.48
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $579k 17,500 shares
Last Trade
Jun 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$356k 17,500 shares
$20.32
$33.09
Albireo Pharma
Albireo Pharma ALBO
Director
Holding Value $0 0 shares
Last Trade
Mar 02, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.03M 46,000 shares
$44.15
$44.15

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up